Sign in
4

Changes in Ownership

Mirum Pharmaceuticals, Inc. Filed Acc 0001209191-23-049511

Director sold 14,608 shares at $32.00 ($467,456)

  • Director acquired 14,608 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

GREY MICHAEL G · Director

Table I: Non-derivative

4 lines
Date Transaction Shares Price Value Owned after D/I
2023-09-13 Exercise or conversion : show line 1 in the form +392 $2.94 $1,151 392 D
2023-09-13 Sale : show line 2 in the form −392 $32.00 $12,544 0 D
2023-09-14 Exercise or conversion : show line 3 in the form +14,216 $2.94 $41,738 14,216 D
2023-09-14 Sale : show line 4 in the form −14,216 $32.00 $454,912 0 D
Open-market sales · 14,608 sh · avg $32.00 · $467,456

Table II: Derivative

2 lines
Date Transaction Shares Owned after D/I
2023-09-13 Exercise or conversion : show line 5 in the form Stock Option (right to buy) −392 345,392 D
2023-09-14 Exercise or conversion : show line 6 in the form Stock Option (right to buy) −14,216 331,176 D
Loading xslF345X05/doc4.xml…